Atlas Trials

Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder (CTNNB1 Gene)

Clinical trial NCT07614126 · RECRUITING

Trial details

NCT number
NCT07614126
Sponsor
University Hospital, Montpellier
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CTNNB1L-DOPA
Start date
2026-04-08
Primary completion
2026-12-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.